Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prophylactic effect of erythropoietin injection to prevent acute mountain sickness: an open-label randomized controlled trial.

Heo K, Kang JK, Choi CM, Lee MS, Noh KW, Kim SB.

J Korean Med Sci. 2014 Mar;29(3):416-22. doi: 10.3346/jkms.2014.29.3.416. Epub 2014 Feb 27.

2.

Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial.

Baillie JK, Thompson AA, Irving JB, Bates MG, Sutherland AI, Macnee W, Maxwell SR, Webb DJ.

QJM. 2009 May;102(5):341-8. doi: 10.1093/qjmed/hcp026. Epub 2009 Mar 9.

3.

Glucocorticoids as prophylaxis against acute mountain sickness.

Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W.

Clin Endocrinol (Oxf). 2002 Dec;57(6):761-7.

PMID:
12460326
4.

Incidence of acute mountain sickness in young adults at 3200 meters: comparison of the Lake Louise Scoring and Chinese Scoring Systems.

Chen GZ, Qin J, Yu J, Gao XB, Dong JQ, Lu W, Bian SZ, Zeng Y, Huang L.

Genet Mol Res. 2013 Dec 16;12(4):6790-801. doi: 10.4238/2013.December.16.5.

5.

Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.

Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM.

Arch Intern Med. 2005 Feb 14;165(3):296-301.

PMID:
15710792
6.

Intraocular pressure is not associated with acute mountain sickness.

Cushing T, Paterson R, Haukoos J, Harris NS.

High Alt Med Biol. 2013 Dec;14(4):342-5. doi: 10.1089/ham.2013.1024.

PMID:
24377341
7.

Non-invasive positive pressure ventilation during sleep at 3800 m: Relationship to acute mountain sickness and sleeping oxyhaemoglobin saturation.

Johnson PL, Popa DA, Prisk GK, Edwards N, Sullivan CE.

Respirology. 2010 Feb;15(2):277-82. doi: 10.1111/j.1440-1843.2009.01678.x. Epub 2009 Dec 27.

8.

Ginkgo biloba does--and does not--prevent acute mountain sickness.

Leadbetter G, Keyes LE, Maakestad KM, Olson S, Tissot van Patot MC, Hackett PH.

Wilderness Environ Med. 2009 Spring;20(1):66-71. doi: 10.1580/08-WEME-BR-247.1.

PMID:
19364166
9.

Change in oxygen saturation does not predict acute mountain sickness on Jade Mountain.

Chen HC, Lin WL, Wu JY, Wang SH, Chiu TF, Weng YM, Hsu TY, Wu MH.

Wilderness Environ Med. 2012 Jun;23(2):122-7. doi: 10.1016/j.wem.2012.03.014.

PMID:
22656657
10.

Index measured at an intermediate altitude to predict impending acute mountain sickness.

Modesti PA, Rapi S, Paniccia R, Bilo G, Revera M, Agostoni P, Piperno A, Cambi GE, Rogolino A, Biggeri A, Mancia G, Gensini GF, Abbate R, Parati G.

Med Sci Sports Exerc. 2011 Oct;43(10):1811-8. doi: 10.1249/MSS.0b013e31821b55df.

PMID:
21448078
11.

Different duration of high-altitude pre-exposure associated with the incidence of acute mountain sickness on Jade Mountain.

Weng YM, Chiu YH, Lynn JJ, Li WC, Wang SH, Kao WF, Hsu TY, Chiu TF, Lin YJ, Chan CW.

Am J Emerg Med. 2013 Jul;31(7):1113-7. doi: 10.1016/j.ajem.2013.03.028. Epub 2013 May 18.

PMID:
23688567
12.

Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness.

Gertsch JH, Corbett B, Holck PS, Mulcahy A, Watts M, Stillwagon NT, Casto AM, Abramson CH, Vaughan CP, Macguire C, Farzan NN, Vo BN, Norvelle RJ, May K, Holly JE, Irons H, Stutz AM, Chapagain P, Yadav S, Pun M, Farrar J, Basnyat B.

Wilderness Environ Med. 2012 Dec;23(4):307-15. doi: 10.1016/j.wem.2012.08.001. Epub 2012 Oct 24.

PMID:
23098412
13.

Rate of ascent and acute mountain sickness at high altitude.

Hsu TY, Weng YM, Chiu YH, Li WC, Chen PY, Wang SH, Huang KF, Kao WF, Chiu TF, Chen JC.

Clin J Sport Med. 2015 Mar;25(2):95-104. doi: 10.1097/JSM.0000000000000098.

PMID:
24751723
14.

Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m.

Schommer K, Wiesegart N, Menold E, Haas U, Lahr K, Buhl H, Bärtsch P, Dehnert C.

High Alt Med Biol. 2010 Spring;11(1):19-25. doi: 10.1089/ham.2009.1019.

PMID:
20367484
15.

Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.

Moraga FA, Flores A, Serra J, Esnaola C, Barriento C.

Wilderness Environ Med. 2007 Winter;18(4):251-7. Erratum in: Wilderness Environ Med. 2008 Spring;19(1):51.

PMID:
18076292
16.

Sumatriptan for prevention of acute mountain sickness: randomized clinical trial.

Jafarian S, Gorouhi F, Salimi S, Lotfi J.

Ann Neurol. 2007 Sep;62(3):273-7.

PMID:
17557349
17.

How can acute mountain sickness be quantified at moderate altitude?

Roeggla G, Roeggla M, Podolsky A, Wagner A, Laggner AN.

J R Soc Med. 1996 Mar;89(3):141-3.

18.

Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent.

Gertsch JH, Seto TB, Mor J, Onopa J.

High Alt Med Biol. 2002 Spring;3(1):29-37.

PMID:
12006162
19.

Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.

Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C.

High Alt Med Biol. 2003 Spring;4(1):45-52.

PMID:
12713711
20.

Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.

van Patot MC, Leadbetter G 3rd, Keyes LE, Maakestad KM, Olson S, Hackett PH.

High Alt Med Biol. 2008 Winter;9(4):289-93. doi: 10.1089/ham.2008.1029.

PMID:
19115912
Items per page

Supplemental Content

Write to the Help Desk